The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival

The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic RivalEli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs.

Powered by WPeMatico

https://www.wired.com/feedFeed: All LatestChannel DescriptionTechnology124Emily Mullin

Leave a Comment

Your email address will not be published. Required fields are marked *


Scroll to Top